Study supports the hypothesis that a food for special medical purposes containing Fortasyn Connect can benefit patients with mild cognitive impairment who are at high risk of progression to the dementia stage of Alzheimer’s disease, according to research published in the Journal of Alzheimer’s Disease Reports.

Source link